Response to: 'Tapering antirheumatic drugs in a resource-poor setting: real-world evidence' by Haroon et al

Elise van Mulligen*, Pascal H. P. de Jong

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Article number209
Number of pages1
JournalAnnals of the Rheumatic Diseases
Issue number10
Publication statusPublished - Oct 2022

Bibliographical note

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and
permissions. Published by BMJ.

Cite this